news about tirzepatide Lilly's new drug Mounjaro (tirzepatide ) wins US FDA approval New Tirzepatide Access and Pricing

Do not rub or massage the injection site immediately after injecting, as this can worsen bleeding from any nicked vessels

Alongside the explosion of GLP-1 medications for diabetes and weight loss management have come logistical, environmental and public health concerns

Their philosophy is Make it right, or dont make it at all

Yes, many people can transition if supply issues or personal choice make Wegovy preferable to Mounjaro

Why women need lower doses Biological differences: Smaller average body size Different hormone profiles More sensitive to some peptides Better response at lower doses often General rule: Start 20-30% lower than male doses Women: 150-200mcg vs Men: 200-300mcg (GH peptides) Titrate based on response More isn't better for women Hormone cycle considerations (perimenopause) If still menstruating: GH peptides: Use consistently throughout cycle Weight loss peptides: May work better in follicular phase (days 1-14) Some women dose higher during luteal phase (more resistant) Track response across full cycle Post-menopause: No cycle to consider Consistent dosing easier More predictable results Age-specific dosing Women 40-50 (perimenopause): Start conservative Body still producing some hormones Lower doses effective Women 50-60 (menopause): Standard doses appropriate Need more GH replacement Can titrate higher if needed Women 60-70+: Start very low Increase slowly More sensitive to side effects Benefits still significant Safety considerations for women over 40 Special precautions for this demographic